IP Library Granted Patent US 10,441,717
Granted Patent B2
US 10,441,717 · App. 14/253,271 · Granted Oct 15, 2019

Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,441,717
App. No.
14/253,271
Granted
Oct 15, 2019
Kind
B2
Abstract

A physiological parameter associated with tissue of a host may be monitored in the tissue to confirm subcutaneous delivery of medication to the host. More particularly, such may involve delivering medication subcutaneously to the host with a medical device which includes a sensor used to measure the physiological parameter, particularly within a predetermined time period after delivery of the medication. Such may also or otherwise involve forming a depot in the tissue with the medication, and using the sensor to measure the physiological parameter while the sensor is at least partially within the depot.

Claims (87)

1. A method of treating a host with a medication, the method comprising:

providing a medication delivery device which deliver the medication into a tissue of the host, wherein the medication delivery device includes a sensor, and wherein the sensor is used to measure a physiological parameter of the tissue;

introducing the medication delivery device including the sensor into the tissue such that the tissue is in contact with the sensor;

delivering the medication into the tissue of the host;

forming a depot in the tissue with the medication, the depot formed such that the sensor is at least partially within the depot with the depot disposed between the sensor and the tissue, wherein the depot is disposed between the sensor and the tissue such that the depot reduces the tissue contact with the sensor;

confirming delivery of the medication from the medication delivery device to the host, wherein confirming delivery of the medication comprises using the sensor to measure the physiological parameter of the tissue within a predetermined time period after delivery of the medication and while the sensor is at least partially within the depot with the depot disposed between the sensor and the tissue.

2. The method of claim 1 wherein:

the tissue in contact with the sensor comprises extracellular fluid; and

the depot reduces contact of the extracellular fluid with the sensor.

3. The method of claim 2 wherein:

the depot reduces contact of the extracellular fluid with the sensor by the depot at least partially surrounding the sensor within the depot.

4. The method of claim 1 wherein:

the predetermined time period is less than a time required for the depot to be completely absorbed into the tissue and the tissue reestablishes contact with the sensor where the depot was located.

5. The method of claim 1 wherein:

the predetermined time period is in a range of 0.1 second to 600 seconds.

6. The method of claim 5 wherein:

the predetermined time period is in a range of 0.1 second to 120 seconds.

7. The method of claim 1 wherein:

delivering the medication into the tissue of the host further comprises delivering the medication into subcutaneous tissue of the host.

8. The method of claim 1 wherein:

the sensor comprises a glucose sensor.

9. The method of claim 1 wherein:

the physiological parameter is glucose concentration level.

10. The method of claim 1 wherein:

confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured within the predetermined time period after delivery of the medication;

providing a predetermined representative value for the physiological parameter with the medication delivery device; and

determining that the measured value of the physiological parameter within the predetermined time period after delivery of the medication is less than the predetermined representative value for the physiological parameter provided by the medication delivery device.

11. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue; and

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

determining a value of the physiological parameter measured within the predetermined time period after delivery of the medication; and

determining that the value of the physiological parameter measured within the predetermined time after delivery of the medication is less than the value of the physiological parameter measured before delivering the medication into the tissue.

12. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue;

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

determining a value of the physiological parameter measured within the predetermined time period after delivery of the medication;

determining a numerical difference between the value of the physiological parameter measured before delivering the medication into the tissue, and the value of the physiological parameter measured within the predetermined time after delivering the medication into the tissue;

providing a predetermined representative value for the numerical difference of the physiological parameter with the medication delivery device; and

determining the numerical difference between the two measured values of the physiological parameter is greater than a predetermined representative value for the numerical difference provided by the medication delivery device.

13. The method of claim 12 wherein:

the physiological parameter is interstitial glucose concentration level; and

a predetermined representative value for the numerical difference provided by the medication delivery device is at least 20 mg/dL.

14. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue;

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

determining a value of the physiological parameter measured within the predetermined time period after delivery of the medication;

determining a percentage change between the value of the physiological parameter measured before delivering the medication into the tissue, and the value of the physiological parameter measured within the predetermined time after delivering the medication into the tissue;

providing a predetermined representative value for the percentage change of the physiological parameter with the medication delivery device; and

determining the percentage change between the two measured values of the physiological parameter is greater than a predetermined representative value for the percentage change provided by the medication delivery device.

15. The method of claim 14 wherein:

the physiological parameter is interstitial glucose concentration level; and

a predetermined representative value for the percentage change provided by the medication delivery device is at least 15%.

16. The method of claim 1 wherein:

confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter while the sensor is within the depot;

providing a predetermined representative value for the physiological parameter with the medication delivery device; and

after delivery of the medication, determining that the measured value of the physiological parameter while the sensor is within the depot is less than the predetermined representative value for the physiological parameter provided by the medication delivery device.

17. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue; and

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

after delivery of the medication, determining a value of the physiological parameter measured while the sensor is within the depot; and

determining that the value of the physiological parameter measured while the sensor is within the depot is less than the value of the physiological parameter measured before delivering the medication into the tissue.

18. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue;

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

after delivery of the medication, determining a value of the physiological parameter measured while the sensor is within the depot;

determining a numerical difference between the value of the physiological parameter measured before delivering the medication into the tissue, and the value of the physiological parameter measured while the sensor is within the depot;

providing a predetermined representative value for the numerical difference of the physiological parameter with the medication delivery device; and

determining the numerical difference between the two measured values of the physiological parameter is greater than a predetermined representative value for the numerical difference provided by the medication delivery device.

19. The method of claim 1 further comprising:

after introducing the medication delivery device including the sensor into the tissue, using the sensor to measure the physiological parameter before delivering the medication into the tissue;

wherein confirming delivery of the medication from the medication delivery device to the host further comprises:

determining a value of the physiological parameter measured before delivering the medication;

after delivery of the medication, determining a value of the physiological parameter measured while the sensor is within the depot;

determining a percentage change between the value of the physiological parameter measured before delivering the medication into the tissue, and the value of the physiological parameter measured while the sensor is within the depot;

providing a predetermined representative value for the percentage change of the physiological parameter with the medication delivery device; and

determining the percentage change between the two measured values of the physiological parameter is greater than a predetermined representative value for the percentage change provided by the medication delivery device.

20. The method of claim 1 wherein:

the medication delivery device includes a cannula.

21. The method of claim 1 further comprising:

forming the depot in the tissue with the medication, the depot formed such that the sensor is completely within the depot with the depot disposed between the sensor and the tissue, wherein the depot disposed between the sensor and the tissue separates the tissue from the sensor such that the depot reduces the tissue contact of the tissue with the sensor.

Assignments (3)
SECURITY INTEREST Recorded May 4, 2021
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 056135/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2018
From: MCLAUGHLIN, IAN T.; O'CONNOR, JASON B.
To: INSULET CORPORATION
Reel/Frame 045143/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2014
From: SCHMID, KEVIN GUIDO; DIIANNI, STEVEN; CAMPBELL, ROBERT W.
To: INSULET CORPORATION
Reel/Frame 032677/0800 →
Cited By (9)
US 12,458,751 US 12,478,733 US 12,496,398 US 12,640,028 US 12,646,601 US 12,651,659 US 12,653,949 US 12,656,151 US 12,673,155